Sato M, Hiragun A, Shudo K
Cancer Lett. 1985 Jan;25(3):261-9. doi: 10.1016/s0304-3835(15)30005-7.
The ability of 4 steric isomers of indolactam-V, the synthetic analogues of the tumor promoter teleocidin, to affect the adipose conversion of ST-13 murine pre-adipose cells was investigated. The isomers share the common skeleton with teleocidin A and B, but unlike teleocidins, none of them possess the terepenoid chain in the molecule. We found that only one of the isomers, (-)-indolactam-V, was biologically active and produced up to 70% inhibition of adipose conversion, while the other 3 isomers were without effect. We propose that the biological activity of indolactam-V isomers as inhibitors of adipose conversion requires the indole- and 9-membered lactam-rings with proper chiral substituents, but does not require the terpenoid chain.
研究了吲哚内酰胺 -V的4种空间异构体(肿瘤促进剂远侧霉素的合成类似物)影响ST -13小鼠前脂肪细胞脂肪转化的能力。这些异构体与远侧霉素A和B具有共同骨架,但与远侧霉素不同的是,它们分子中均不具有萜类链。我们发现,只有其中一种异构体(-)-吲哚内酰胺 -V具有生物活性,可产生高达70%的脂肪转化抑制作用,而其他3种异构体则无此作用。我们提出,吲哚内酰胺 -V异构体作为脂肪转化抑制剂的生物活性需要带有适当手性取代基的吲哚环和9元内酰胺环,但不需要萜类链。